Page last updated: 2024-08-18

cyclohexanol and Carcinoma, Ductal, Breast

cyclohexanol has been researched along with Carcinoma, Ductal, Breast in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Flockhart, DA; Hayes, DF; Henry, NL; Riba, M; Stearns, V1
Barton, DL1

Reviews

1 review(s) available for cyclohexanol and Carcinoma, Ductal, Breast

ArticleYear
Drug interactions and pharmacogenomics in the treatment of breast cancer and depression.
    The American journal of psychiatry, 2008, Volume: 165, Issue:10

    Topics: Adrenergic Uptake Inhibitors; Antidepressive Agents; Antineoplastic Agents, Hormonal; Biotransformation; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclohexanols; Cytochrome P-450 CYP2D6; Cytochrome P-450 CYP2D6 Inhibitors; Delayed-Action Preparations; Depressive Disorder, Major; Drug Interactions; Drug Therapy, Combination; Female; Genotype; Hot Flashes; Humans; Middle Aged; Pharmacogenetics; Selective Serotonin Reuptake Inhibitors; Tamoxifen; Treatment Outcome; Venlafaxine Hydrochloride

2008

Other Studies

1 other study(ies) available for cyclohexanol and Carcinoma, Ductal, Breast

ArticleYear
Menopausal symptoms following tamoxifen treatment for breast cancer.
    Oncology (Williston Park, N.Y.), 2008, Volume: 22, Issue:4 Suppl Nu

    Topics: Antidepressive Agents, Second-Generation; Antineoplastic Agents, Hormonal; Breast Neoplasms; Carcinoma, Ductal, Breast; Cyclohexanols; Female; Hot Flashes; Humans; Menopause; Middle Aged; Relaxation Therapy; Tamoxifen; Venlafaxine Hydrochloride

2008